Jeff N. Hunter
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Jeff N. Hunter
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 | |
| Public Company | Other Consumer Specialties | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jeff N. Hunter tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| IMMUCOR, INC. | Medical Specialties | Director/Board Member | |
| WOLFSPEED, INC. | Semiconductors | Chairman Founder Director/Board Member | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
Equitel, Inc.
 Equitel, Inc. Specialty TelecommunicationsCommunications Equitel, Inc. provides prepaid telecommunications services. It provides cellular telephone, prepaid telephony solutions to retailers, distributors, communications service providers, business service providers, and consumers. Equitel was founded in 1999 and is headquartered in Raleigh, NC. | Specialty Telecommunications | Director of Finance/CFO | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Director/Board Member Chief Executive Officer Founder | |
KNOW Bio LLC
 KNOW Bio LLC Pharmaceuticals: MajorHealth Technology KNOW Bio LLC engages in the development and optimization of a nitric oxide platform providing therapies that focuses on curing diseases and conditions. The company was founded in 2015 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Kansas | College/University | Graduate Degree Undergraduate Degree | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| North Carolina State University | College/University | Doctorate Degree Undergraduate Degree | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Founder Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Corporate Officer/Principal Doctorate Degree | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Director of Finance/CFO | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| ALSP ORCHID ACQUISITION CORPORATION I | Financial Conglomerates | Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Wisconsin-Milwaukee | College/University | Undergraduate Degree | |
| GIGABEAM CORPORATION | Wireless Telecommunications | Director of Finance/CFO | |
Athenix Corp.
 Athenix Corp. Chemicals: AgriculturalProcess Industries Athenix Corp. develops agricultural herbicide tolerance and insect control chemicals. It provides genes, proteins, processes, traits, and transgenic organisms for multiple sectors including seed, agricultural chemical, specialty chemical, industrial enzymes, and energy. The company was founded by Duck Nicholas Barbara, Carozzi Nadine and Koziel Michael Gene in 2001 and is headquartered in Raleigh, NC. | Chemicals: Agricultural | Director of Finance/CFO | |
Xenex Disinfection Services, Inc.
 Xenex Disinfection Services, Inc. Medical SpecialtiesHealth Technology Xenex Disinfection Services, Inc. provides ultraviolet room disinfection systems for healthcare facilities. The firm's patented pulsed xenon UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities and due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The company eliminates harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company was founded by Julie A. Stachowiak, Brian Cruver and Mark Stibich in August 2008 and is headquartered in San Antonio, TX. | Medical Specialties | Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| University of Illinois At Urbana–Champaign | College/University | Graduate Degree | |
| Western Illinois University | College/University | Undergraduate Degree | |
Altan Pharma Ltd.
 Altan Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021. | Pharmaceuticals: Major | Director/Board Member | |
| NORDION INC | Pharmaceuticals: Major | Director/Board Member | |
Transition Bio, Inc.
 Transition Bio, Inc. BiotechnologyHealth Technology Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles. | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 37 |
| Irlanda | 5 |
| Norvegia | 2 |
| Regno Unito | 2 |
| Canada | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 8 |
| Commercial Services | 3 |
| Communications | 3 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 97 |
| Corporate Officer/Principal | 45 |
| Chairman | 35 |
| Independent Dir/Board Member | 29 |
| Director of Finance/CFO | 27 |
Contatti più connessi
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Sean Murphy | 22 |
| George Martin | 21 |
| Robert Keegan | 16 |
| Richard Peterson | 13 |
| Mark Hahn | 13 |
| Paula Stafford | 12 |
| A. Sanders | 11 |
| William L. Hodges | 9 |
| Frederick Russ | 9 |
| Brian Johnson | 6 |
| Sean P. Andrews | 6 |
| John Gay | 6 |
| Eugene Sun | 6 |
| Kent Geer | 6 |
- Borsa valori
- Insiders
- Jeff N. Hunter
- Connessioni Società
